N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis



Status:Recruiting
Conditions:Schizophrenia, Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - 35
Updated:7/11/2015
Start Date:May 2011
End Date:May 2017
Contact:Corin Pilo, MA
Email:cpilo@bidmc.harvard.edu
Phone:617-998-5016

Use our guide to learn which trials are right for you!

Effects of Oral N-Acetyl-Cysteine (NAC) in the Early Phase of Schizophrenia Spectrum Psychosis: Randomized, Parallel, Double- Blind, Placebo Controlled Trial

The investigators seek to examine the effect of add-on N-Acetyl-Cysteine (NAC) in the early
phase of schizophrenia spectrum illness in collaboration with researchers Kim Do, PhD, and
Philippe Conus, MD in Switzerland. Modifications of brain structure are thought to occur
during the pre-illness phase and around the transition to psychosis. Therefore, studying new
treatments that could target changes occurring during this period is of critical importance.

Aims:

Does add-on NAC treatment in early psychosis influence:

- positive and negative symptoms

- extrapyramidal side-effects of other medication

- plasma concentration of glutathione

- Mismatch Negativity, a physiological marker

The study proposes that a glutathione deficit leading to an abnormal response to oxidative
stress is a vulnerability factor, combined with other brain specific factors, in brain
functioning of some individuals with schizophrenia (Do et al., 2010). N-acetyl-cysteine is
hypothesized to cross the blood-brain barrier and increase glutathione in the brain.

Inclusion Criteria:

- Capacity to provide informed consent

- DSM IV TR diagnosis of schizophrenia, schizophreniform, schizoaffective

- Psychiatric and medical stability

- Prescribing clinician's premission to participate, assurance of medical stability

- Having met threshold criteria for psychosis on CAARMS (Comprehensive Assessment of at
Risk Mental States Scale) Psychosis subscale

- Up to 12 months of antipsychotic treatment

Exclusion Criteria:

- Severe medical comorbidities

- Previous cerebral trauma

- Substance induced psychosis or organic psychosis

- Mental retardation

- NAC allergy

- Pregnancy, females and males planning pregnancy

- Treatment with antioxidants

- Insufficient command of English
We found this trial at
2
sites
330 Brookline Ave
Boston, Massachusetts 02215
617-667-7000
Beth Israel Deaconess Medical Center Beth Israel Deaconess Medical Center (BIDMC) is one of the...
?
mi
from
Boston, MA
Click here to add this to my saved trials
Boston, Massachusetts 02215
?
mi
from
Boston, MA
Click here to add this to my saved trials